These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35896894)

  • 21. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
    Shah M; Woo HG
    Front Immunol; 2021; 12():830527. PubMed ID: 35140714
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Wang H; Li C; Obadan AO; Frizzell H; Hsiang TY; Gil S; Germond A; Fountain C; Baldessari A; Roffler S; Kiem HP; Fuller DH; Lieber A
    Hum Gene Ther; 2022 Apr; 33(7-8):389-403. PubMed ID: 35057635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.
    Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA; Thiam K; Kjems J; Pedersen FS; Howard KA
    Acta Biomater; 2022 Nov; 153():411-418. PubMed ID: 36162760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2.
    C SK; Kumar SA; Wei H
    Toxicol Rep; 2020; 7():1366-1372. PubMed ID: 33052306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease.
    Raedle-Hurst T; Wissing S; Mackenstein N; Obeid R; Geisel J; Wagenpfeil S; Abdul-Khaliq H
    Clin Res Cardiol; 2022 Feb; 111(2):154-162. PubMed ID: 33280062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.
    Sheikhi A; Hojjat-Farsangi M
    Hum Vaccin Immunother; 2021 Jan; 17(1):92-97. PubMed ID: 32663051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD-sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID-19).
    Sun P; Lu X; Xu C; Wang Y; Sun W; Xi J
    J Med Virol; 2020 Oct; 92(10):1721-1723. PubMed ID: 32232976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of Soluble Angiotensin Converting Enzyme 2 (sACE2) in Children and Adults with and without COVID-19.
    Wissing SI; Obeid R; Rädle-Hurst T; Rohrer T; Herr C; Schöpe J; Geisel J; Bals R; Abdul-Khaliq H
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors.
    Alfaleh MA; Zawawi A; Al-Amri SS; Hashem AM
    MAbs; 2022; 14(1):2057832. PubMed ID: 35380919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
    Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
    J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
    Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
    MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between soluble angiotensin-converting enzyme 2 in saliva and SARS-CoV-2 infection: a cross-sectional study.
    Bru S; Brotons P; Jordan I; Alsina L; Henares D; Carballar R; de Sevilla MF; Barrabeig I; Fumado V; Baro B; Martínez-Láinez JM; Garcia-Garcia JJ; Bassat Q; Balaguer A; Clotet J; Launes C; Muñoz-Almagro C
    Sci Rep; 2023 Apr; 13(1):5985. PubMed ID: 37045853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
    Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants.
    Wang B; Zhao J; Liu S; Feng J; Luo Y; He X; Wang Y; Ge F; Wang J; Ye B; Huang W; Bo X; Wang Y; Xi JJ
    Emerg Microbes Infect; 2022 Dec; 11(1):1488-1499. PubMed ID: 35587428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants.
    Zakir TS; Meng T; Carmen LCP; Chu JJH; Lin RTP; Prabakaran M
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
    Xiao T; Lu J; Zhang J; Johnson RI; McKay LGA; Storm N; Lavine CL; Peng H; Cai Y; Rits-Volloch S; Lu S; Quinlan BD; Farzan M; Seaman MS; Griffiths A; Chen B
    Nat Struct Mol Biol; 2021 Feb; 28(2):202-209. PubMed ID: 33432247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants.
    Zhang L; Dutta S; Xiong S; Chan M; Chan KK; Fan TM; Bailey KL; Lindeblad M; Cooper LM; Rong L; Gugliuzza AF; Shukla D; Procko E; Rehman J; Malik AB
    bioRxiv; 2021 Dec; ():. PubMed ID: 34981059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17.
    Niehues RV; Wozniak J; Wiersch F; Lilienthal E; Tacken N; Schumertl T; Garbers C; Ludwig A; Düsterhöft S
    FASEB J; 2022 Mar; 36(3):e22234. PubMed ID: 35199397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.